XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,032.2 $ 334.7
Restricted cash 98.9 75.3
Accounts receivable - trade, net of allowance for doubtful accounts of $13.8 at September 30, 2020 and $12.4 at December 31, 2019 3,776.2 4,873.6
Accounts receivable - related parties 4.1 2.5
Inventories 3,192.6 2,091.4
Derivative assets 132.9 127.2
Prepaid and other current assets 556.4 358.2
Total current assets 8,793.3 7,862.9
Property, plant and equipment, net 42,360.1 41,603.4
Investments in unconsolidated affiliates 2,485.4 2,600.2
Intangible assets, net of accumulated amortization of $1,796.8 at September 30, 2020 and $1,687.5 at December 31, 2019 3,348.6 3,449.0
Goodwill 5,745.2 5,745.2
Other assets 1,003.6 472.5
Total assets 63,736.2 61,733.2
Current liabilities:    
Current maturities of debt 1,325.0 1,981.9
Accounts payable - trade 896.0 1,004.5
Accounts payable - related parties 121.3 162.3
Accrued product payables 4,317.1 4,915.7
Accrued interest 235.1 431.7
Derivative liabilities 329.7 122.4
Other current liabilities 622.7 511.2
Total current liabilities 7,846.9 9,129.7
Long-term debt 28,537.0 25,643.2
Deferred tax liabilities 463.3 100.4
Other long-term liabilities 735.2 1,032.4
Commitments and contingent liabilities
Redeemable preferred limited partner interests:    
Series A cumulative convertible preferred units (50,000 units outstanding at September 30, 2020) 49.1  
Partners' equity    
Common limited partner interests (2,182,880,979 units issued and outstanding at September 30, 2020 and 2,189,226,130 units issued and outstanding at December 31, 2019) 26,381.9 24,692.6
Treasury units, at cost (1,297.3) 0.0
Accumulated other comprehensive income (loss) (49.3) 71.4
Total partners' equity 25,035.3 24,764.0
Noncontrolling interests in consolidated subsidiaries 1,069.4 1,063.5
Total equity 26,104.7 25,827.5
Total liabilities, preferred units, and equity $ 63,736.2 $ 61,733.2